Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) has been named to Fortune magazine's 2025 World's Most Admired Companies™ list for the 11th consecutive year. The company ranked third in the 'Health Care: Pharmacy and Other Services' category, achieving top positions in seven of nine evaluation criteria.

The selection process, conducted in collaboration with Korn Ferry, involved surveying thousands of executives, directors, and analysts who rated companies based on nine key attributes including quality of products and services, innovation, and social responsibility. Quest secured top 1 or 2 positions in areas such as quality of management, long-term investment, product and service quality, social responsibility, and people management.

With over 55,000 employees, Quest Diagnostics continues its mission of creating a healthier world under the leadership of Chairman, CEO and President Jim Davis. Companies must rank in the top half of their industry survey to be included in this prestigious list, which analyzed 650 companies in total.

News Market Reaction

-0.65%

1 alert

-0.65% News Effect

On the day this news was published, DGX declined 0.65%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SECAUCUS, N.J., Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.

The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.

"Every day, the more than 55,000 colleagues of Quest Diagnostics bring our purpose to life: working together to create a healthier world, one life at a time," said Jim Davis, Chairman, CEO and President. "Their commitment to living our purpose in service to our customers and patients is the reason we continue to be recognized among Fortune's World's Most Admired Companies."

In addition to the overall ranking, Quest was number three in the "Health Care: Pharmacy and Other Services" industry category. Quest ranked in the top 1 or 2 spot of seven of nine criteria that comprise the industry category, including quality of management, long-term investment, product and service quality, social responsibility and people management.

Consulting firm Korn Ferry collaborated with Fortune to survey thousands of executives, directors and analysts who rated companies in their industry on nine criteria, analyzing a total of 650 companies. A company's score must rank in the top half of its industry survey to be listed as a World's Most Admired Company.

Find more information on the 2025 Fortune's World's Most Admired Companies here.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-named-to-fortunes-worlds-most-admired-companies-list-for-11th-consecutive-year-302364831.html

SOURCE Quest Diagnostics

FAQ

What ranking did Quest Diagnostics (DGX) achieve in Fortune's 2025 World's Most Admired Companies list?

Quest Diagnostics ranked third in the 'Health Care: Pharmacy and Other Services' category and was named to the World's Most Admired Companies list for the 11th consecutive year.

How many evaluation criteria did DGX excel in for the 2025 Fortune ranking?

Quest Diagnostics ranked in the top 1 or 2 positions in seven out of nine evaluation criteria, including quality of management, long-term investment, and social responsibility.

What was the selection process for Fortune's 2025 World's Most Admired Companies list?

The selection process involved Korn Ferry surveying thousands of executives, directors, and analysts who rated 650 companies based on nine key attributes, with companies needing to rank in the top half of their industry to be listed.

How many employees does Quest Diagnostics have in 2025?

Quest Diagnostics has more than 55,000 employees working towards their purpose of creating a healthier world.

What key attributes were evaluated for DGX's inclusion in Fortune's 2025 list?

Companies were evaluated on nine key attributes including quality of products and services, innovation, community responsibility, social responsibility, and talent management.